blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2385839

EP2385839 - THERAPEUTIC COMPOSITIONS FOR TREATMENT OF CORNEAL DISORDERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.10.2015
Database last updated on 19.07.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
THE SCHEPENS EYE RESEARCH INSTITUTE, INC.
20 Staniford Street
Boston, MA 02114 / US
[2011/46]
Inventor(s)01 / DANA, Reza
165 Pleasant Street
Cambridge MA 02139 / US
02 / DASTJERDI, Mohammed
9408 Alhambra Street
Prairie Village KS 66207 / US
03 / CHAUHAN, Sunil
85 Mt. Vernon Street
Apt. 4
Somerville, MA 02145 / US
 [2011/46]
Representative(s)Lahrtz, Fritz, et al
Patentanwälte
Isenbruck Bösl Hörschler PartG mbB
Prinzregentenstraße 68
81675 München / DE
[N/P]
Former [2013/15]Mintz Levin Cohn Ferris Glovsky and Popeo LLP
Alder Castle
10 Noble Street
London EC2V 7JX / GB
Former [2011/46]Clarke, Victoria, et al
Mintz Levin Cohn Ferris Glovsky and Popeo Intellectual Property LLP Alder Castle 10 Noble Street
London EC2V 7JX / GB
Application number, filing date10700459.011.01.2010
WO2010US20646
Priority number, dateUS20090143561P09.01.2009         Original published format: US 143561 P
[2011/46]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010081091
Date:15.07.2010
Language:EN
[2010/28]
Type: A2 Application without search report 
No.:EP2385839
Date:16.11.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 15.07.2010 takes the place of the publication of the European patent application.
[2011/46]
Type: B1 Patent specification 
No.:EP2385839
Date:26.11.2014
Language:EN
[2014/48]
Search report(s)International search report - published on:EP18.11.2010
ClassificationIPC:A61K38/17, C12N15/113, A61P27/02, A61K38/20, A61K9/00
[2014/28]
CPC:
A61K38/1709 (EP,US); A61K38/1793 (EP,US); A61K38/2006 (EP,US);
A61K9/0048 (EP,US); A61P27/02 (EP); A61P37/00 (EP);
C12N15/1136 (EP,US); C12N2310/14 (EP,US) (-)
C-Set:
A61K38/1709, A61K2300/00 (EP,US)
Former IPC [2011/46]A61K38/17, C12N15/113, A61P27/02
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2014/48]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:THERAPEUTISCHE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON HORNHAUTERKRANKUNGEN[2011/46]
English:THERAPEUTIC COMPOSITIONS FOR TREATMENT OF CORNEAL DISORDERS[2011/46]
French:COMPOSITIONS THÉRAPEUTIQUES POUR LE TRAITEMENT DE TROUBLES DE LA CORNÉE[2011/46]
Entry into regional phase08.08.2011National basic fee paid 
08.08.2011Designation fee(s) paid 
08.08.2011Examination fee paid 
Examination procedure08.08.2011Examination requested  [2011/46]
09.03.2012Amendment by applicant (claims and/or description)
02.01.2013Despatch of a communication from the examining division (Time limit: M06)
19.08.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
18.10.2013Reply to a communication from the examining division
28.05.2014Cancellation of oral proceeding that was planned for 03.06.2014
03.06.2014Date of oral proceedings (cancelled)
08.07.2014Communication of intention to grant the patent
16.10.2014Fee for grant paid
16.10.2014Fee for publishing/printing paid
16.10.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.01.2013
Opposition(s)27.08.2015No opposition filed within time limit [2015/45]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
18.10.2013Request for further processing filed
18.10.2013Full payment received (date of receipt of payment)
Request granted
31.10.2013Decision despatched
Fees paidRenewal fee
25.01.2012Renewal fee patent year 03
25.01.2013Renewal fee patent year 04
27.01.2014Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU11.01.2010
AT26.11.2014
BG26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
ES26.11.2014
FI26.11.2014
HR26.11.2014
IT26.11.2014
LT26.11.2014
LV26.11.2014
MK26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
SM26.11.2014
TR26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
[2018/30]
Former [2017/38]HU11.01.2010
AT26.11.2014
BG26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
ES26.11.2014
FI26.11.2014
HR26.11.2014
IT26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
SM26.11.2014
TR26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2016/12]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
ES26.11.2014
FI26.11.2014
HR26.11.2014
IT26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2016/03]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
ES26.11.2014
FI26.11.2014
HR26.11.2014
IT26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SE26.11.2014
SK26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/37]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
ES26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
SE26.11.2014
SK26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/36]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
ES26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
RO26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/35]AT26.11.2014
CY26.11.2014
DK26.11.2014
EE26.11.2014
ES26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/26]AT26.11.2014
CY26.11.2014
ES26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/25]AT26.11.2014
ES26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/24]ES26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/23]ES26.11.2014
FI26.11.2014
LT26.11.2014
NL26.11.2014
NO26.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/22]LT26.11.2014
NO26.02.2015
PT26.03.2015
Former [2015/21]LT26.11.2014
NO26.02.2015
Former [2015/20]LT26.11.2014
Cited inInternational search[XI]WO9822130  (SCHEPENS EYE RES INST [US], et al) [X] 1-17,20,21 * abstract * * page 19, line 32 - page 20, line 5 * [I] 18,19,22,33;
 [XP]WO2009089036  (SCHEPENS EYE RES INST [US], et al) [XP] 1-22 * claims 33-41 *
 [XI]  - BISWAS PARTHA SARATHI ET AL, "Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein", JOURNAL OF LEUKOCYTE BIOLOGY, (200410), vol. 76, no. 4, ISSN 0741-5400, pages 868 - 875, XP002582634 [X] 1-17,20,21 * abstract * [I] 18,19,22,33
 [XI]  - BARRETT R ET AL, "Combined antibiotic and IL-1 receptor antagonist treatment decreases stromal inflammation after P. aeruginosa induced keratitis", IOVS, & ANNUAL MEETING OF THE ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY; FORT LAUDERDALE, FLORIDA, USA; APRIL 29-MAY 04, 2001, (20010315), vol. 42, no. 4, page S252, XP009133601 [X] 1-17,20,21 * abstract * [I] 18,19,22,33
 [XI]  - YAMADA JUN ET AL, "Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury.", EXPERIMENTAL EYE RESEARCH FEB 2003 LNKD- PUBMED:12565803, (200302), vol. 76, no. 2, ISSN 0014-4835, pages 161 - 167, XP002582629 [X] 1-17,20,21 * abstract * [I] 18,19,22,33

DOI:   http://dx.doi.org/10.1016/S0014-4835(02)00293-2
 [XI]  - JIE YING ET AL, "Interleukin-1 receptor antagonist eye drops promoting high-risk corneal allografts survival in rats", CHINESE MEDICAL JOURNAL (ENGLISH EDITION), (200405), vol. 117, no. 5, ISSN 0366-6999, pages 711 - 716, XP009133597 [X] 1-17,20,21 * abstract * [I] 18,19,22,33
by applicantUS2005033694
 US2001041792
 US6974682
 US2006094663
 US2005171337
 US2005105830
 US2001042304
 US6927044
 US2003026806
 US2004022718
 US2005023872
 US6623736
 US2003083301
 US2009136453
 US2008242634
 WO2009089036
    - YAMASAKI ET AL., STROKE, (1995), vol. 26, pages 676 - 681
    - BERNOIST ET AL., NATURE, (1981), vol. 290, page 304
    - YAMAMOTO ET AL., CELL, (1988), vol. 22, pages 787 - 797
    - WAGNER ET AL., PROC. NATL. ACAD. SCI. USA, (1981), vol. 78, page 1441
    - BRINSTER ET AL., NATURE, (1988), vol. 296, page 39
    - PONS ET AL., EUR. RESPIR. J., (2002), vol. 20, pages 458 - 463
    - AKEDA ET AL., SPINE, (2007), vol. 32, pages 635 - 642
    - DEKOSKY ET AL., ANN. NEUROL., (1996), vol. 39, pages 123 - 127
    - TEMPORIN ET AL., NEUROSCI LETT., (2008), vol. 440, no. 2, pages 130 - 3
    - RYOKE ET AL., BIOCHEM BIOPHYS RES COMMUN., (2000), vol. 267, no. 3, pages 715 - 8
    - GUCNARD ET AL., J NCUROSCI RCS., (1991), vol. 29, no. 3, pages 396 - 400
    - MüLLER ET AL., EXP EYE RES, (2003), vol. 76, pages 521 - 42
    - MüLLCR ET AL., INVEST OPHTHALMOL VIS SCI, (1996), vol. 37, pages 476 - 88
    - DARTT, DA, OCUL SURF, (2004), vol. 2, pages 76 - 91
    - BATTAT ET AL., OPHTHALMOLOGY, (2001), vol. 108, pages 1230 - 5
    - XU, CORNEA, (1996), vol. 15, pages 235 - 9
    - DINARELLO, C.A., BLOOD, (1996), vol. 15, pages 2095 - 2147
    - JIANG, Y. ET AL., ARTHRITIS RHEUM., (2000), vol. 43, pages 1001 - 1009
    - OKUSAWA, S. ET AL., J CLIN INVEST., (1988), vol. 81, pages 1162 - 1172
    - MCDEVITT, M.J. ET AL., J. PERIODONTOL., (2000), vol. 71, pages 156 - 163
    - AREND, W.P., ADV IMMUNOL., (1993), vol. 54, pages 167 - 223
    - FISHER, C.J., JAMA, (1994), vol. 271, pages 1836 - 1843
    - BRESNIHAN, B. ET AL., RHEUM DIS CLIN NORTH AM., (1998), vol. 24, no. 3, pages 615 - 628
    - DAYER, J.M., CURR OPIN RHCUMATOL., (2001), vol. 13, pages 170 - 176
    - EDWARDS, C.K., J CLIN RHCUMATOL., (2001), vol. 7, pages S17 - S24
    - REIFF, A., CURR RHEUMATOL REP., (2005), vol. 7, pages 434 - 40
    - ANTIN, J.H. ET AL., BLOOD, (1994), vol. 84, pages 1342 - 8
    - TEOH, S.C. ET AL., BR J OPTHALMOL., (2007), vol. 91, pages 263 - 4
    - CARON, J.P ET AL., ARTHRITIS RHEUM., (1996), vol. 39, pages 1535 - 44
    - HYNNINEN, M. ET AL., J CRIT CARE., (1999), vol. 14, pages 63 - 8
    - LARSEN, C.M. ET AL., N ENGL J. MED., (2007), vol. 356, pages 1517 - 26
    - YAMADA, J. ET AL., INVEST OPTHALMOL VIS SCI., (2000), vol. 41, pages 4203 - 8
    - KEANE-MYERS, A.M. ET AL., INVEST OPTHALMOL VIS SCI., (1999), vol. 40, pages 3041 - 6
    - YAMADA, J. ET AL., EXP EYE RES., (2003), vol. 76, pages 161 - 7
    - O'NCILL, L. A. J.; GREENE, C., JOURNAL OF LEUKOCYTE BIOLOGY., (1998), vol. 63, pages 650 - 657
    - FOULKS; BRON, OCUL SURF, (2003), pages 107 - 26
 WO2008US09776
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.